Clinical Trials in Baltimore

Showing 18721-18740 of 23,476 trials

Randomized Trial of Suicide Gene Therapy and Prostate Cancer

NCT00583492

This is a randomized, controlled trial that will test the hypothesis that replication-competent adenovirus-mediated suicide gene therapy in combination with 80 Gy intensity modulated radiotherapy (IRMT)will improve freedom from failure (FFF) relative to 80 Gy IMRT alone in patients with newly-diagnosed prostate cancer with an intermediate-risk profile.

Prostate Cancer

Henry Ford Health System44 participantsStarted Dec 2007

Baltimore, Maryland, United States • Detroit, Michigan, United States

COMPLETEDPhase 1/2< 1 mile

Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions

NCT01003106

The primary Objective of this study is to evaluate the safety and tolerability of intraocular injections of 0.5mg or 2.0mg of ranibizumab in patients with macular edema due to retinal vein occlusion.

Retinal Vein Occlusion

Peter A Campochiaro, MD81 participantsStarted Nov 2009

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

NCT00735397

The purpose of this study was to evaluate the safety and tolerability of perampanel (up to 12 mg/day) given as adjunctive treatment in subjects with refractory partial seizures and to evaluate the maintenance of effect of perampanel for the control of refractory partial seizures.

Epilepsy

Eisai Inc.1,218 participantsStarted Oct 2008

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +236 more locations

Randomized Trial of Suicide Gene Therapy and Prostate Cancer

Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Find Trials by Condition in Baltimore

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia

Post-Approval Study of MelaFind

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

Study of the Diffusion of a Smoking Cessation Application Through an Online Network

Impact of Feeding on Pro-Inflammatory Cytokine Response in Neonates Receiving a RBC Transfusion

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole

Bosutinib For Autosomal Dominant Polycystic Kidney Disease

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)

APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients